ArticleJournal of veterinary internal medicine2026
Sequential measurement of serum amyloid A concentrations in ill hospitalized neonatal foals.
Article in Journal of veterinary internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evaluation of sequential serum amyloid A measurements for the prediction of sepsis and survival in critically ill neonatal foals.Journal of veterinary internal medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn hospitalized foals, limited data are available on the utility of sequential measurement of SAA concentrations and the value of these data in a clinical setting. HYPOTHESIS/
objectivesTo determine serum amyloid A (SAA) concentrations in ill neonatal foals at multiple timepoints during hospitalization, and to evaluate a potential association with systemic inflammatory response syndrome (SIRS) status, blood culture (BC) result, and survival. ANIMALS: Hospitalized ill foals (n = 90, ≤ 14 days).
methodsIn this retrospective study, foals were classified based on SIRS criteria: "SIRS" or "NonSIRS," BC results, and survival. Serum amyloid A concentrations on admission (ADM), day 1 (D1) and day 2 (D2) were compared within and between groups, using nonparametric tests. Results are presented as median (IQR) (effect size; 95% CI).
resultsSerum amyloid A concentrations were higher in SIRS than in NonSIRS foals both on ADM (401 mg/L (99; 855) vs 67 mg/L (23; 685), [ES 129, 95% CI, 15-385]), and on D1 (836 mg/L (616; 1240) vs 212 mg/L (69; 890), [ES 501, 95% CI, 121-724]). On D2, but not on ADM, foals with a positive BC had higher SAA (1244 mg/L (757; 2004)) than BC negative foals (153 mg/L (57; 695), [ES 1002; 95% CI, 282-1418]). On D1, but not on ADM, SAA was higher in non-survivors (729 mg/L (469; 1347) than in survivors (323 mg/L (75; 889), [ES 373; 95% CI, 28-651]). CONCLUSIONS AND CLINICAL IMPORTANCE: Serum amyloid A measurements on D1 and D2 of hospitalization likely reflect both the severity of disease and response to initial treatment. Repeated SAA measurements during hospitalization can aid clinicians in determining severity of disease and can be useful as a prognosticator in ill neonatal foals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.